Accessibility Statement Skip Navigation
  • PRNewswire.com
  • Resources
  • +91 22-69790010
  • Client Login
  • Send a Release
PR Newswire: news distribution, targeting and monitoring
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please use Advanced Search to search all press releases.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • General Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • Telephone

    • +91 22-69790010 from 9 AM - 5:30 PM IST

    • Contact
    • Contact

      +91 22-69790010
      from 9 AM - 5:30 PM IST

  • When typing in this field, a list of search results will appear and be automatically updated as you type.

  • Request More Information
  • Journalists
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Request More Information
  • Journalists
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • Request More Information
  • Journalists
  • General Inquiries
  • Worldwide Offices
  • Request More Information
  • Journalists

Global Biosimilars Market was Valued at 6738.14 Million US$ in 2018 and is Expected to Reach 28903.56 Million US$ With a CAGR of 23.12% by 2025 - Valuates Reports™
  • USA - English

Valuates_Reports_Logo

News provided by

Valuates Reports

30 Oct, 2019, 18:15 IST

Share this article

Share toX

Share this article

Share toX

BANGALORE, India, Oct. 30, 2019 /PRNewswire/ --

GLOBAL BIOSIMILARS MARKET OVERVIEW :

"Growing pressure to reduce healthcare expenditure is one of the factors largely attributing to the growth of the Global Biosimilars Market"

It is expected that the Global Biosimilars Market will highlight opportunities such as the advent of bio-better drugs, demand in emerging markets, and new biological product indications and patent expiry.

The Global Biosimilars Market is expected to grow from USD 6738.14 Millions in 2018 to USD 28903.56 Millions by the end of 2025 at a CAGR of 23.12%.

With strict regulatory requirements adversely affecting investment in the biosimilars market and high investment needed for research and development, the market may face potential growth challenges in the near future. The key players on the market, however, are making efforts to produce creative deals and benchmark approaches in the global market for biosimilars.

Inquire for Sample : https://reports.valuates.com/request/sample/360I-Auto-2K21/Global_Biosimilars_Market

FACTORS DRIVING THE MARKET

●  Growing pressure to reduce healthcare expenditure
●  Lower cost biosimilars drugs than original biologics
●  Growing demands of pharmaceutical drugs
●  Supportive government initiative and awareness creating programs in the developing economies
●  Expiration of major patents during the forecast period

However, some factors such as Reluctance of physicians to prescribe biosimilars and Unawareness among patients and preference for brand may hinder the market growth.

View Full Report : https://reports.valuates.com/market-reports/360I-Auto-2K21/global-biosimilars-market

ON THE BASIS OF INDICATION, THE GLOBAL BIOSIMILARS MARKET IS STUDIED ACROSS

●  Autoimmune Diseases
●  Blood Disorders
●  Chronic Diseases
●  Growth Hormone Deficiency
●  Infectious Diseases
●  Oncology

ON THE BASIS OF PRODUCT, THE GLOBAL BIOSIMILARS MARKET IS STUDIED ACROSS

●  Recombinant Glycosylated Proteins
●  Recombinant Non-Glycosylated Proteins
●  Recombinant Peptides

ON THE BASIS OF MANUFACTURING, THE GLOBAL BIOSIMILARS MARKET IS STUDIED ACROSS
●  Contract Manufacturing
●  In-House Manufacturing

"Bioton S.A. the potential growing player for the Global Biosimilars Market"

THIS REPORT FOCUSES ON THE GLOBAL TOP PLAYERS, COVERED

●  Amgen Inc
●  Biogen
●  Dr. Reddy's Laboratories Limited
●  Mylan N.V.
●  Pfizer Inc
●  Sandoz International Gmbh
●  AMEGA Biotech S.A.
●  Apotex
●  Biosidus
●  Bioton S.A.
●  Innovent Biologics, Inc
●  Others

Buy Now @ https://reports.valuates.com/api/directpaytoken?rcode=360I-Auto-2K21

RESEARCH METHODOLOGY:

Our market forecasting is based on a market model derived from market connectivity, dynamics, and identified influential factors around which assumptions about the market are made. These assumptions are enlightened by fact-bases, put by primary and secondary research instruments, regressive analysis and an extensive connect with industry people.

Market forecasting derived from in-depth understanding obtained from future market spending patterns provides quantified insight to support your decision-making process. The interview is recorded, and the information gathered in put on the drawing board with the information collected through secondary research.

Inquire For Regional/Countries :

https://reports.valuates.com/request/regional/360I-Auto-2K21/Global_Biosimilars_Market

THE REPORT PROVIDES INSIGHTS ON THE FOLLOWING POINTERS:

●  Market Penetration: Provides comprehensive information on sulfuric acid offered by the key players in the Global Biosimilars Market
●  Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments in the Global Biosimilars Market
●  Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets for the Global Biosimilars Market
●  Market Diversification: Provides detailed information about new products launches, untapped geographies, recent developments, and investments in the Global Biosimilars Market
●  Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the Global Biosimilars Market

THE REPORT ANSWERS QUESTIONS SUCH AS:

●  What is the market size of Biosimilars market in the Global?
●  What are the factors that affect the growth in the Global Biosimilars Market over the forecast period?
●  What is the competitive position in the Global Biosimilars Market?
●  Which are the best product areas to be invested in over the forecast period in the Global Biosimilars Market?
●  What are the opportunities in the Global Biosimilars Market?
●  What are the modes of entering the Global Biosimilars Market?

Request For Custom Research : https://reports.valuates.com/request/customisation/360I-Auto-2K21/Global_Biosimilars_Market

REPORTS COVERING SPECIFIC SUBSETS OF BIOSIMILARS MARKET

Global Biosimilar Drug Market : https://reports.valuates.com/market-reports/QYRE-Auto-13155/global-biosimilar-drug-market

mAb Biosimilar Market: https://reports.valuates.com/market-reports/PROF-Auto-13M1261/global-mab-biosimilar

Hereceptin Biosimilar Market: https://reports.valuates.com/market-reports/PROF-Auto-1W18/global-hereceptin-biosimilar

ABOUT US :

Our aim is to collate unparalleled Market insights and notify our customers as and when it happens. Valuates is curating premium Market Research Reports from the leading publishers around the globe. We will help you map your information needs to our report repository of Market research reports and guide you through your purchasing decision.

We are based out of Silicon Valley of India (Bengaluru) and provide 24/7 online and offline support to all our customers and just a phone call away.

CONTACT US:

Valuates Reports
[email protected]
For U.S. Toll Free Call :  +1(315)215-3225
For IST Call :  +91-8040957137
WhatsApp : +91-9945648335
Website: https://reports.valuates.com
LinkedIn: https://www.linkedin.com/company/valuatesreports/

Logo: https://mma.prnewswire.com/media/825036/Valuates_Reports_Logo.jpg

Modal title

Contact PR Newswire

  • +91 22-69790010

Global Sites

  • APAC
  • APAC - Traditional Chinese
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany

 

  • India
  • Indonesia
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland

 

  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921
Global Sites
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States
+91 (0) 22 6169 6000
from 9 AM - 5:30 PM IST
  • Terms of Use
  • Privacy Policy
  • GDPR
  • Information Security Policy
  • Site Map
  • Cookie Settings
Copyright © 2026 Cision US Inc.